Short Interest in BetterLife Pharma Inc. (OTCMKTS:BETRF) Declines By 67.1%

BetterLife Pharma Inc. (OTCMKTS:BETRF) was the target of a large decline in short interest in the month of November. As of November 15th, there was short interest totalling 7,300 shares, a decline of 67.1% from the October 31st total of 22,200 shares. Based on an average trading volume of 23,900 shares, the short-interest ratio is currently 0.3 days.

BetterLife Pharma Stock Performance

Shares of OTCMKTS BETRF traded up $0.01 during trading on Thursday, reaching $0.09. The stock had a trading volume of 25,900 shares, compared to its average volume of 28,930. The business’s 50-day moving average price is $0.09 and its 200-day moving average price is $0.09. BetterLife Pharma has a fifty-two week low of $0.03 and a fifty-two week high of $0.15. The company has a market cap of $11.75 million, a P/E ratio of -3.03 and a beta of 1.27.

BetterLife Pharma (OTCMKTS:BETRF) last posted its quarterly earnings results on Wednesday, September 25th. The company reported ($0.01) EPS for the quarter.

BetterLife Pharma Company Profile

BetterLife Pharma Inc, a biotechnology company, engages in the development and commercialization of compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections.